Clinical Trials on Peripheral Vascular Disease in Australia

Total 13435 results

Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS): ACTIVATE II (ACTIVATEII)

PAD - Peripheral Arterial Disease

Australia
Biotronik CRC Inc.
Biotronik AG

Active, not recruiting

BRight DCB First-in-Human Study

Peripheral Artery Disease

New Zealand, Australia, Germany, Austria
Monash University
Monash Health

Recruiting

Carnosine for Peripheral Vascular Disease (Car-PVD)

Peripheral Arterial Disease

Australia
Alucent Biomedical

Active, not recruiting

Feasibility Study of the Vessel Restoration System (VRS) for the Treatment of Atherosclerotic Lesions in the Superficial Femoral Artery (SFA) and/or Popliteal Artery (PA) After Sub-optimal Percutaneous Transluminal Angioplasty (PTA) or Atherectomy: REACTIVATE I (REACTIVATE I)

PAD - Peripheral Arterial Disease

Australia
Biotronik CRC Inc.

Not yet recruiting

BRight Pharmacokinetic Study

Peripheral Artery Disease

Australia
Flinders University
The Queen Elizabeth Hospital; Flinders Medical Centre; Royal Adelaide Hospital

Completed

Effect of Exercise Training on Protein Expression in Skeletal Muscle Tissue After Exercise in Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Shockwave Medical, Inc.

Completed

Disrupt PAD+ Study With the Shockwave Medical M5+ Peripheral IVL System (Disrupt PAD+)

Peripheral Arterial Disease | Vascular Disease, Peripheral

New Zealand, Australia, United States
Biotronik AG

Active, not recruiting

BIO REsponse Adapted Combination Therapy Pilot Study

Peripheral Arterial Disease

Australia, Belgium, France, Germany, Austria, Spain
Bayside Health

Completed

Angiotensin Converting Enzyme (ACE) Inhibition and Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Baker Heart Research Institute

Completed

The Effects of Ramipril on Clinical Symptoms in Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Amplitude Vascular Systems, Inc.

Active, not recruiting

POWER: Pulse Intravascular Lithotripsy (Pulse IVL) to Open Vessels With Calcific Walls and Enhance Vascular Compliance and Remodeling (POWER-PAD-1)

Peripheral Arterial Disease

Australia, New Zealand, Dominican Republic
Cook Group Incorporated

Completed

Zilver PTX Delivery System

Peripheral Vascular Disease

New Zealand, Australia, Germany
Bayside Health
National Health and Medical Research Council, Australia

Terminated

Effects of Niacin on Good Cholesterol in People With Peripheral Arterial Disease

Peripheral Arterial Disease

Australia
Symic Vascular
Symic Biomedical, Inc.

Unknown

Angioplasty + SBCV vs. Angioplasty Alone for Femoropopliteal Artery Stenosis (SHIELD)

Peripheral Arterial Disease

Australia, New Zealand
Efemoral Medical, Inc.

Recruiting

The Efemoral Vascular Scaffold System (EVSS) for the Treatment of Patients With Symptomatic Peripheral Vascular Disease From Stenosis or Occlusion of the Femoropopliteal Artery (Efemoral I)

Vascular Diseases | Peripheral Arterial Disease | Stenosis | Femoropopliteal Stenosis

New Zealand, Australia
C. R. Bard

Active, not recruiting

Study of BD Sirolimus Drug Coated Catheter for Treatment of Femoropopliteal Arteries (PREVISION)

Peripheral Arterial Disease | Peripheral Artery Disease | Stenosis Artery

Australia, New Zealand, Singapore
SurModics, Inc.

Completed

Safety and Feasibility of Surmodics SUNDANCE™ Drug Coated Balloon (SWING)

Peripheral Arterial Disease | Critical Lower Limb Ischemia

New Zealand, Australia, Austria, Germany, Latvia
Vienna General Hospital

Completed

PTA vs. Primary Stenting of SFA Using Self-Expandable Nitinol Stents

Peripheral Vascular Diseases | Intermittent Claudication | Angioplasty

Austria
Shockwave Medical, Inc.

Active, not recruiting

Mini S Feasibility Study With Shockwave Medical Mini S Peripheral IVL System

Peripheral Arterial Disease

New Zealand, Australia
Biotronik AG
Biotronik, Inc.

Unknown

Study to Determine the Performance of the Astron and Pulsar-18 Stents in Europe (BIOFLEX-I EU)

Peripheral Vascular Disease | Peripheral Artery Disease

Germany, Belgium, Austria, Switzerland
Royal Brisbane and Women's Hospital

Unknown

Peripheral Venous Catheter Trial: 3 Day Versus No Routine Change

Phlebitis

Australia
Medical University of Vienna

Unknown

Exercise Training Versus Best Medical Treatment Only in Peripheral Artery Disease

Peripheral Artery Disease

Austria
Guerbet

Completed

Efficacy Evaluation of Dotarem Compared to Gadovist in the Diagnosis of Peripheral Arterial Disease (DALIA)

Peripheral Arterial Disease

Austria
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease II (RAPID II)

Peripheral Arterial Disease

Austria
Hoffmann-La Roche

Completed

A Multiple Ascending Dose Study of RO4905417 in Healthy Volunteers and Patients With Peripheral Arterial Disease (PAD).

Peripheral Arterial Disease (PAD)

United States, Canada, Australia
Sanofi
Bristol-Myers Squibb

Completed

CASPAR : Clopidogrel and Acetyl Salicylic Acid in Bypass Surgery for Peripheral ARterial Disease

Arterial Occlusive Diseases

France, Spain, Italy, Belgium, Germany, Hungary, Poland, Australia, Austria, Netherlands, Sweden, United Kingdom, Finland, Switzerland
Baker Heart and Diabetes Institute

Terminated

The Effects of Metformin on Functional Capacity in Individuals With Peripheral Artery Disease-Related Intermittent Claudication

Peripheral Arterial Disease | Intermittent Claudication

Australia
C. R. Bard

Completed

Bard® LifeStent® Vascular Stent Delivery System Study

Peripheral Vascular Disease

Austria, Germany
Medical University of Graz
AIT Austrian Institute of Technology GmbH

Completed

A Usability Study of a Tele-health Service for Patients With Peripheral Arterial Disease.

Peripheral Arterial Disease

Austria
AstraZeneca
Pretium Pty Ltd

Completed

Audit and Screening Study to Determine the Prevalence of Peripheral Arterial Disease (ACHILLES)

Peripheral Arterial Disease

Australia
Medical University Innsbruck

Recruiting

Mitochondrial Function in Peripheral Arterial Disease (MIVA)

Cardiovascular Diseases | Peripheral Arterial Disease

Austria
Monash University
Novartis Pharmaceuticals

Recruiting

VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN) (v-ASCERTAIN)

Cerebrovascular Disease | Coronary Heart Disease (CHD) | Peripheral Arterial Disease (PAD) | Atherosclerotic Cardiovascular Disease (ASCVD)

Australia
Abbott Medical Devices

Completed

A Safety and Efficacy Study of the Dynalink®-E Everolimus Eluting Peripheral Stent System (STRIDES)

Atherosclerosis | Peripheral Vascular Disease

Germany, Austria, Belgium, Italy
Biotronik AG

Completed

BIOLUX P-I First in Man Study

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Vascular Disease

Germany, Austria
Philips Clinical & Medical Affairs Global

Completed

Tack Optimized Balloon Angioplasty Below the Knee (TOBA - BTK) Study (TOBABTK)

Peripheral Artery Disease | Critical Limb Ischemia

Austria
Biotronik AG

Completed

BIOLUX P-II First-in-Man Study to Compare the Passeo-18 Lux DRB Against POBA in Infrapopliteal Arteries (BIOLUX P-II)

Arteriosclerosis | Atherosclerosis | Peripheral Artery Disease | Vascular Disease

Belgium, Austria, Germany
Corindus Inc.

Completed

Robotic-Assisted Peripheral Intervention for Peripheral Arterial Disease (RAPID)

Peripheral Arterial Disease

Austria
Medical University of Vienna

Completed

OMEGA-3-Polyunsaturated Fatty-Acids (N3-Pufa) In Patients With Peripheral Arterial Disease

Peripheral Arterial Disease

Austria
Medical University of Vienna

Unknown

Paclitaxel Balloon Versus Standard Balloon in In-stent Restenoses of the Superficial Femoral Artery (PACUBA I Trial) (PACUBA 1)

Peripheral Arterial Disease

Austria
The University of New South Wales

Terminated

The ABSORB Bioresorbable Scaffold Below the Knee (BTK) Study

Ischemia | Arterial Occlusive Diseases | Peripheral Arterial Disease (PTA

New Zealand, Australia, Netherlands
Elixir Medical Corporation
Massachusetts General Hospital; Syntactx; Genae

Completed

The DESappear Study: Drug Eluting Scaffold (DESappear)

Peripheral Vascular Disease

New Zealand, Austria, Germany, Belgium
Medical University of Vienna

Unknown

Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT) (NASCIT)

Atherosclerosis | Dyslipidemia

Austria
Abbott Medical Devices

Completed

ESPRIT I: A Clinical Evaluation of the Abbott Vascular ESPRIT BVS (Bioresorbable Vascular Scaffold) System

Atherosclerosis | Peripheral Vascular Disease | Claudication

Austria, France, Germany, Belgium
Boston Scientific Corporation

Recruiting

Drug-Eluting Registry: Real-World Treatment of Lesions in the Peripheral Vasculature (ELEGANCE)

Peripheral Vascular Diseases

United States, Australia, Taiwan, Canada, Thailand, Austria, Germany, Spain, France, China, Poland
Cordis Corporation
FCRE (Foundation for Cardiovascular Research and Education)

Completed

PMCF Study for Peripheral Arteries Below the Knee (BTK)

Peripheral Artery Disease

Austria, Germany
Biotronik AG

Completed

BIOTRONIK 4French for AMBulatory Peripheral Intervention (BIO4AMB)

Peripheral Artery Disease | Access Site Complication | Outpatient Treatment

France, Austria, Belgium, Switzerland
Biotronik AG

Completed

BIOLUX P-III All-Comers Passeo-18 Lux Registry

Atherosclerosis | Peripheral Artery Disease

France, Germany, Spain, Belgium, Singapore, Austria, Netherlands, Malaysia, Italy, Switzerland, Denmark, Portugal, Australia, Finland, Latvia, Slovakia
Cagent Vascular LLC

Completed

PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator DevicE (PRELUDE)

Peripheral Arterial Disease

New Zealand, Austria, Poland
Flanders Medical Research Program

Completed

Drug Eluting Stents In The Critically Ischemic Lower Leg 2 (DESTINY 2)

Peripheral Arterial Disease

Germany, Australia, Belgium
Shockwave Medical, Inc.

Completed

Safety and Performance Study of the Shockwave Lithoplasty System (DISRUPT-PAD)

Peripheral Arterial Disease

Austria, Germany, New Zealand

Clinical Trials on Peripheral Vascular Disease in Australia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Burundi

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations